Home » Topics » Regulatory

Regulatory
RSS

Effexor XR cleared by FDA

Oct. 28, 1997

Encouraging preliminary results for finasteride in androgenic alopecia

Oct. 23, 1997

Lower dose version of Caverject introduced

Oct. 23, 1997

Oxis Turbuhaler launched in U.K.

Oct. 23, 1997

Trazodone evaluated in patients with erectile dysfunction

Oct. 23, 1997

FDA clears Dermagraft-TC for new indication

Oct. 23, 1997

Biovail and Technilab Pharma sign marketing agreement

Oct. 23, 1997

FDA advisory committee to review finasteride for alopecia

Oct. 22, 1997

NeoPharm moves LED to phase I for prostate cancer

Oct. 22, 1997

FDA clears generic transdermal nicotine product

Oct. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...